CoChat
Sign Up
Cited by 66Pharmaceutical industry and healthcareGlobal Public Health Policies and EpidemiologyPharmaceutical Economics and Policy

Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia

Open access
Grundy, Quinn, Habibi, Roojin, Shnier, Adrienne, Mayes, Christopher, Lipworth, Wendy·2018·Health Policy
DOI 10.1016/j.healthpol.2018.03.015
Open this paper in CoChat — free accountOpen PDF

Abstract

"Sunshine" policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, and is unlikely to be effective on its own, it is important to understand why disclosure has emerged as a predominant public policy solution, and what the effects of this focus on transparency might be. We used Carol Bacchi's problem-questioning approach to policy analysis to compare the Sunshine policies in three different jurisdictions, the United States, France and Australia. We found that transparency had emerged as a solution to several different problems including misuse of tax dollars, patient safety and public trust. Despite these differences in the origins of disclosure policies, all were underpinned by the questionable assumption that informed consumers could address conflicts of interest. We conclude that, while transparency reports have provided an unprecedented opportunity to understand the reach of industry within healthcare, policymakers should build upon these insights and begin to develop policy solutions that address systemic commercial influence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.healthpol.2018.03.015

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Thacker P. The slow pace of success in a Do Something Congress, in Edmond J Safra Center for Ethics. Harvard University: Cambridge, MA; 2013.

Cited by

Sorted by citations

Related

Authors
Grundy, Q., Habibi, R., Shnier, A., Mayes, C., & Lipworth, W.
Affiliations
  • The University of Sydney (AU)
  • University of Ottawa (CA)
  • York University (CA)
Corresponding author
Grundy, Quinn
ORCID
Venue
Health Policy
Publisher
Elsevier BV
Published
2018-05
Volume
122
Issue
5
Pages
509-518
ISSN
0168-8510 (ISSN-L)
DOI
10.1016/j.healthpol.2018.03.015
OpenAlex
W2791345158
Cited by
66
References
30
Citations by year
2026: 1 · 2025: 6 · 2024: 13 · 2023: 4 · 2022: 12 · 2021: 10 · 2020: 8 · 2019: 7 · 2018: 5
FWCI
1.45
Type
journal article
Language
en
Open access
Licence
Locations
  • Health Policy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders
  • Canadian Institutes of Health Research
  • Medical Research Council
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
conflicts of interest, Sunshine Policy, financial disclosure, transparency, pharmaceutical industry influence, transparency reports, public trust, patient safety, comparative health policy, United States, France, Australia
MeSH terms
Australia, Drug Industry, France, Humans, Policy Making, Public Policy, United States, Conflict of Interest, Disclosure, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review